Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | EC50 | 0.09 μM | Inhibition of pseudotyped HIV/EBOV GP infected in human A549 cells assessed as reduction in virus entry measured after 48 hrs by luciferase reporter gene assay | [PMID: 32490678] |
| HeLa | EC50 | 0.67 μM | Antiviral activity against Ebola virus 1976 Mayinga infected in human HeLa cells pretreated for 1 hr followed by virus infection measured after 24 hrs by Hoechst staining-based immunofluorescence assay | [PMID: 32490678] |
| HeLa | EC50 | 3.25 μM | Antiviral activity against Marburg virus Lake Victoria, 2005 Angola infected in human HeLa cells pretreated for 1 hr followed by virus infection measured after 24 hrs by Hoechst staining-based immunofluorescence assay | [PMID: 32490678] |
| Huh-7 | CC50 | 9.31 μM | Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability by cellular ATP method | [PMID: 35872393] |
| MCF-10A | IC50 | > 100 μM | Cytotoxicity against human MCF10A cells by MTT assay | [PMID: 31546197] |
| MCF7 | IC50 | 7 μM | Antiproliferative activity against human MCF7 cells by MTT assay | [PMID: 31546197] |
| MDA-MB-231 | IC50 | 13 μM | Antiproliferative activity against human MDA-MB-231 cells by MTT assay | [PMID: 31546197] |
| Vero | CC50 | 10.11 μM | Cell viability measured by CellTiter-Glo assay in Vero cells at MOI 0.05 after 72hr | 10.1101/2020.03.20.999730 |
| Vero | IC50 | 3.58 μM | Antiviral activity against SARS-CoV-2 (viral titer) measured by plaque assay in Vero cells at MOI 0.0125 after 24 hr | 10.1101/2020.03.20.999730 |
9 records · Scroll to view more